Beyond Basic Probiotics: An Ingredient Platform Built for the GLP-1 Era

Patented in the US, EU, and South Korea — flexible for branded products or custom formulations targeting metabolic health.

The JBD probiotic family is protected by patents in major markets (USA: US11273188; EU & UK: EP3375448; South Korea: KR102125548) with the claim for "gut microbes or pharmaceutical composition or functional food containing the same, having anti-obesity efficacy by lowering fatty acid concentration of the gut fluid contents in a mammalian gastrointestinal tract for the prevention and treatment of obesity and obesity related diseases".

Consequently, the JBD strains offer a differentiated approach to weight management and metabolic health with several distinct advantages over existing interventions:

Unlike conventional probiotics, the JBD strains possess a unique, scientifically validated and safe mechanism—selective fatty acid absorption—that extends their benefits beyond traditional gut health support to include body weight stabilization, visceral fat reduction, and improvement of cardiovascular risk markers (triglycerides, total cholesterol, LDL).

The scientific evidence positions JBD supplementation as a versatile intervention across multiple applications:

  1. Primary weight management for individuals unwilling or unable to implement dietary restrictions or exercise regimens.
  2. Post-pharmacological intervention to support weight stabilization and avoid the common challenge of weight regain.
  3. Metabolic health optimization in patients with dyslipidemia.
  4. General gut health maintenance through traditional probiotic mechanisms including lactate and short-chain fatty acid production.

Competitive advantages

  • Compared to orlistat or other pharmaceutical interventions, JBD strains demonstrate efficacy without the gastrointestinal adverse effects that compromise treatment adherence.
  • Compared to lifestyle intervention, the intake of the probiotic JBD bacteria is easy to implement in the daily routine and ensures a high compliance.
  • The synergistic combination with prebiotic fibers, particularly GOS and PHGG, enhances both colonization and metabolite production.
  • JBD strains can be incorporated as individual components or as a complete three-strain formulation, offering flexibility for branded finished products or custom ingredient solutions targeting the growing health-conscious consumer segment seeking evidence-based, safe, and well-tolerated metabolic support.
Order Samples Book Product Consult